Your browser doesn't support javascript.
loading
Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains.
Wiener, John J M; Gomez, Laurent; Venkatesan, Hariharan; Santillán, Alejandro; Allison, Brett D; Schwarz, Kimberly L; Shinde, Shirin; Tang, Liu; Hack, Michael D; Morrow, Brian J; Motley, S Timothy; Goldschmidt, Raul M; Shaw, Karen Joy; Jones, Todd K; Grice, Cheryl A.
Afiliação
  • Wiener JJ; Johnson & Johnson Pharmaceutical Research & Development L.L.C., 3210 Merryfield Row, San Diego, CA 92121, USA. Jwiener@prdus.jnj.com
Bioorg Med Chem Lett ; 17(10): 2718-22, 2007 May 15.
Article em En | MEDLINE | ID: mdl-17382544
ABSTRACT
We have previously reported a novel class of tetrahydroindazoles that display potency against a variety of Gram-positive and Gram-negative bacteria, potentially via interaction with type II bacterial topoisomerases. Herein are reported SAR investigations of this new series. Several compounds possessing broad-spectrum potency were prepared. Further, these compounds exhibit activity against multidrug-resistant Gram-positive microorganisms equivalent to that against susceptible strains.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Inibidores Enzimáticos / Inibidores da Topoisomerase II / Indazóis / Antibacterianos Idioma: En Revista: Bioorg Med Chem Lett Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2007 Tipo de documento: Article País de afiliação: Estados Unidos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Inibidores Enzimáticos / Inibidores da Topoisomerase II / Indazóis / Antibacterianos Idioma: En Revista: Bioorg Med Chem Lett Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2007 Tipo de documento: Article País de afiliação: Estados Unidos